BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29271397)

  • 1. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
    Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
    Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
    López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
    Hou L; Li Q; Yu Y; Li M; Zhang D
    Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).
    Dykes SS; Gao C; Songock WK; Bigelow RL; Woude GV; Bodily JM; Cardelli JA
    Mol Carcinog; 2017 Feb; 56(2):722-734. PubMed ID: 27434882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
    Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
    Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.
    Orellana-Serradell O; Herrera D; Castellón EA; Contreras HR
    Asian J Androl; 2019; 21(5):460-467. PubMed ID: 30880686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
    Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
    Graham TR; Zhau HE; Odero-Marah VA; Osunkoya AO; Kimbro KS; Tighiouart M; Liu T; Simons JW; O'Regan RM
    Cancer Res; 2008 Apr; 68(7):2479-88. PubMed ID: 18381457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer.
    Farfán N; Ocarez N; Castellón EA; Mejía N; de Herreros AG; Contreras HR
    Sci Rep; 2018 Jul; 8(1):11467. PubMed ID: 30065348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.
    Fang C; Zan J; Yue B; Liu C; He C; Yan D
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1204-1211. PubMed ID: 27862275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
    Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
    Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 modulates endometrial receptivity through epithelial-mesenchymal transition in endometrial epithelial cells in vitro.
    Ran J; Yang HH; Huang HP; Huang HL; Xu Z; Zhang W; Wang ZX
    Biochem Biophys Res Commun; 2020 May; 525(3):699-705. PubMed ID: 32139122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
    Cai W; Zhang Q
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.
    Selth LA; Das R; Townley SL; Coutinho I; Hanson AR; Centenera MM; Stylianou N; Sweeney K; Soekmadji C; Jovanovic L; Nelson CC; Zoubeidi A; Butler LM; Goodall GJ; Hollier BG; Gregory PA; Tilley WD
    Oncogene; 2017 Jan; 36(1):24-34. PubMed ID: 27270433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.